53
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Novel Nomogram to Predict Prognosis in Elderly Early-Stage Hepatocellular Carcinoma Patients After Ablation Therapy

, , &
Pages 901-911 | Received 12 Jan 2024, Accepted 07 May 2024, Published online: 16 May 2024

References

  • Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2007;5(8):938–45, 945.e1–e4. doi:10.1016/j.cgh.2007.02.039
  • Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–2015: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–e567. doi:10.1016/S2214-109X(18)30127-X
  • Ayuso C, Rimola J, Vilana R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol. 2018;101:72–81. doi:10.1016/j.ejrad.2018.01.025
  • Cheng AL, Amarapurkar D, Chao Y, et al. Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: consensus recommendations and review by an International Expert Panel. Liver Int. 2014;34(2):174–183. doi:10.1111/liv.12314
  • Wu CC. Progress of liver resection for hepatocellular carcinoma in Taiwan. Japan J Clin Oncol. 2017;47(5):375–380. doi:10.1093/jjco/hyx007
  • Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191(1):38–46. doi:10.1016/S1072-7515(00)00261-1
  • Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236(4):397–406; discussion 406–7. doi:10.1097/00000658-200210000-00001
  • Yasunaga H, Horiguchi H, Matsuda S, et al. Relationship between hospital volume and operative mortality for liver resection: data from the Japanese Diagnosis Procedure Combination database. Hepatol Res. 2012;42(11):1073–1080. doi:10.1111/j.1872-034X.2012.01022.x
  • Wicks JS, Dale BS, Ruffolo L, et al. Comparable and complimentary modalities for treatment of small-sized HCC: surgical resection, radiofrequency ablation, and microwave ablation. J Clin Med. 2023;12(15):5006. doi:10.3390/jcm12155006
  • Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489 doi:10.4321/s1886-36552014000400007.
  • Rea F, Corrao G, Mancia G. Risk of Dementia during antihypertensive drug therapy in the elderly. J Am Coll Cardiol. 2024;83(13):1194–1203. doi:10.1016/j.jacc.2024.01.030
  • Morita T, Yamamoto K, Ozaki A, Tsuda K, Tanimoto T. The oldest-old in China. Lancet. 2017;390(10097):846–847. doi:10.1016/S0140-6736(17)31830-5
  • Wang CM, Chen ZX, Ma PC, et al. Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study. BMC Surg. 2023;23(1):323. doi:10.1186/s12893-023-02230-0
  • Zhou H, Chen J, Liu K, Xu H. Prognostic factors and predictive nomogram models for early death in elderly patients with hepatocellular carcinoma: a population-based study. Front Mol Biosci. 2023;10:1275791. doi:10.3389/fmolb.2023.1275791
  • Wu FH, Shen CH, Luo SC, et al. Liver resection for hepatocellular carcinoma in oldest old patients. World J Surg Oncol. 2019;17(1):1. doi:10.1186/s12957-018-1541-0
  • Nozawa A, Kubo S, Takemura S, et al. Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century. Surg Today. 2015;45(7):851–857. doi:10.1007/s00595-014-0994-1
  • Inoue Y, Tanaka R, Fujii K, et al. Surgical outcome and hepatic regeneration after hepatic resection for hepatocellular carcinoma in elderly patients. Digest Surg. 2019;36(4):289–301. doi:10.1159/000488327
  • Minami Y, Aoki T, Hagiwara S, Kudo M. Tips for Preparing and practicing thermal ablation therapy of hepatocellular carcinoma. Cancers. 2023;15(19):4763. doi:10.3390/cancers15194763
  • Zou YW, Ren ZG, Sun Y, et al. The latest research progress on minimally invasive treatments for hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int. 2023;22(1):54–63. doi:10.1016/j.hbpd.2022.08.004
  • Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232(3):381–391. doi:10.1097/00000658-200009000-00010
  • Ceppa EP, Collings AT, Abdalla M, et al. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm. Surg Endosc. 2023;37(12):8991–9000. doi:10.1007/s00464-023-10468-1
  • Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
  • Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev. 2005;31(5):380–402. doi:10.1016/j.ctrv.2005.04.012
  • Osawa M, Akuta N, Suzuki F, et al. Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus. J med Virol. 2017;89(12):2144–2148. doi:10.1002/jmv.24890
  • Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. The Lancet. Oncology. 2008;9(7):629–635. doi:10.1016/S1470-2045(08)70153-0
  • Poisson J, Martinez-Tapia C, Heitz D, et al. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcop Musc. 2021;12(6):1477–1488. doi:10.1002/jcsm.12776
  • Zhang X, Pang L, Sharma SV, Li R, Nyitray AG, Edwards BJ. Malnutrition and overall survival in older patients with cancer. Clin Nutr. 2021;40(3):966–977. doi:10.1016/j.clnu.2020.06.026
  • Guo H, Wu T, Lu Q, et al. Hepatocellular carcinoma in elderly: clinical characteristics, treatments and outcomes compared with younger adults. PLoS One. 2017;12(9):e0184160. doi:10.1371/journal.pone.0184160
  • Ding W, Yu J, Liu F, et al. Percutaneous microwave ablation versus robot-assisted hepatectomy for early hepatocellular carcinoma: a real-world single-center study. Digestive Liver Dis. 2022;54(2):243–250. doi:10.1016/j.dld.2021.04.008
  • Koza A, Bhogal RH, Fotiadis N, Mavroeidis VK. The role of ablative techniques in the management of hepatocellular carcinoma: indications and outcomes. Biomedicines. 2023;11(4). doi:10.3390/biomedicines11041062
  • Galle PR, Tovoli F, Foerster F, Wörns MA, Cucchetti A, Bolondi L. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy. J Hepatol. 2017;67(1):173–183. doi:10.1016/j.jhep.2017.03.007
  • Nevola R, Tortorella G, Rosato V, et al. Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma. Biology. 2023;12(7):984. doi:10.3390/biology12070984
  • Greten TF, Villanueva A, Korangy F, et al. Biomarkers for immunotherapy of hepatocellular carcinoma. Nature reviews. Clin Oncol. 2023;20(11):780–798. doi:10.1038/s41571-023-00816-4